Nebracetam

Nebracetam

Systematic (IUPAC) name
(RS)-4-(Aminomethyl)-1-benzylpyrrolidin-2-one
Clinical data
Legal status
Legal status	US: Not FDA approved; unscheduled
Identifiers
CAS Number	97205-34-0
ATC code	none
PubChem	CID 65926
ChemSpider	59334
UNII	T30038QI8N
ChEMBL	CHEMBL2104682
Chemical data
Formula	C12H16N2O
Molar mass	204.268 g/mol
Chirality	Racemic mixture
SMILES O=C2N(Cc1ccccc1)CC(C2)CN
InChI InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2 Key:LCAFGJGYCUMTGS-UHFFFAOYSA-N
(verify)

Nebracetam is an investigational drug of the racetam family that is a M₁ acetylcholine receptor agonist in rats.^[1] Its effects in humans have not been studied.

See also

• Piracetam
• Aniracetam
• Racetam

References

1. Takeo, S.; Hayashi, H.; Miyake, K.; Takagi, K.; Tadokoro, M.; Takagi, N.; Oshikawa, S. (1997). "Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats". British Journal of Pharmacology 121 (3): 477–484. doi:10.1038/sj.bjp.0701161. PMC 1564714. PMID 9179389.